Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9MD7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,113
Award facts
- Contract value 100% obligated
- $21,112.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $21,112.67 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) on January 21, 2026, with an ultimate completion date of January 22, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. The company's IDC with DLA enables it to supply a comprehensive range of pharmaceutical products and medical commodities globally to support military treatment facilities and government healthcare programs. Vraylar, a neurological treatment medication, falls within the extensive therapeutic portfolio covered under this prime vendor contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies essential to the Defense Health Agency and other federal healthcare customers.
Quick answers
Who was awarded contract SPE2DR26F9MD7?
SPE2DR26F9MD7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9MD7 worth?
The government has obligated $21,113 on SPE2DR26F9MD7.
Is contract SPE2DR26F9MD7 an order under another contract?
Yes. SPE2DR26F9MD7 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MD7 competed?
The extent of competition for SPE2DR26F9MD7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award